Dr. Brian Bressler

Gastroenterologist · Ulcerative Colitis · Crohn's Disease · Vancouver, British Columbia
  • 89 Publications

Dr. Brian Bressler is a Clinical Assistant Professor of Medicine in the Division of Gastroenterology at the University of British Columbia Department of Medicine. Having received his MD from the University of British Columbia, Dr. Bressler completed his residency at the Internal Medicine and Gastroenterology at the University of Toronto, after which he received an MS in Epidemiology from the Harvard Public School of Health and an Advanced Fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital, Harvard Medical School.

Following his advanced training at Harvard Medical School, Dr. Bressler has continued to treat patients, educate students and shares his insights with fellow gastroenterologists at patient education events. He is also a member of the GI Research Institute in Vancouver, one of the most active gastroenterology research centers in North America.

"Participating in a clinical trial can offer you an opportunity that really can be better than anything else you have available. "
-Dr. Brian Bressler

Popular Health Findings By Dr. Brian Bressler

What is crohn s disease

What is Crohn’s Disease?

What is Crohn’s disease? If you have Crohn’s disease it means that you have inflammation of the lining of your digestive or gastrointestinal (GI) ...

Rectal therapy in ulcerative colitis an option that shouldn t be overlooked

Rectal Therapy In Ulcerative Colitis: An Option That Shouldn’t be Overlooked

If you cringe at the thought of using a rectal therapy in your ulcerative colitis treatment plan, you’re not alone. Most people consider them to be...

Humira (Adalimumab)

What is it? Humira is a protein that partially inhibits the activity of the immune system by blocking the inflammatory molecules causing inflammat...

Simponi (Golimumab)

What is it? Simponi is a protein that partially inhibits the activity of the immune system by blocking the inflammatory molecules causing inflamma...

Cannabis for crohn s disease and ulcerative colitis

Cannabis for Crohn's Disease and Ulcerative Colitis

Many people with Crohn's disease or ulcerative colitis have expressed interest in trying medical marijuana to manage their symptoms. Others have si...

What new treatments for crohn s and colitis are being developed

What New Treatments for Crohn’s and Colitis Are Being Developed?

Great efforts are being made to find new treatments for people with inflammatory bowel disease (IBD), specifically the two main forms of IBD: Crohn...

Dr. Brian Bressler

Popular diets for crohn s disease and ulcerative colitis

Popular Diets for Crohn's Disease and Ulcerative Colitis

As previously discussed, diet can play a major role in the management of Crohn's disease and ulcerative colitis. With so much information currently...

Ashley Charlebois

27-year-old female with ulcerative colitis requiring 5-ASA suppositories

Age: 27 Gender: female The important feature of this management plan is that the patient understood the importance of using her suppositories bey...

Dr. Brian Bressler


Discover therapies

Chief Medical Officer

Discover Therapies · 2016 - Present

Our mission is to transform patients’ access to new treatment options to improve their health and accelerate research to find cures. The search for new treatments and cures progresses at a glacial pace, starving many patients of the opportunity to have better treatments and cures in their lifetime. We are changing this by connecting patients with the cutting-edge treatments options that are available to them through research. By making this connection simple for patients and simple for researchers, we will find cures faster. Our passion for empowering patients, our decades of experience in clinical research and our expertise with technology are enabling us to break down the barriers in research. With a community of over 30,000 patients and researchers rallying with us, we are not the only ones excited about our mission.

University of british columbia

Director, Advanced IBD Training Program

University of British Columbia · 2007 - Present

Clinical Associate Professor of Medicine, Division of Gastroenterology

Providence health care


Providence Health Care · 2007 - Present


GI Research Institute and Pacific Gastroenterology · 2005 - Present

The Gastrointestinal (GI) Clinic at St. Paul’s provides endoscopic procedures on an outpatient, inpatient, and emergency basis. It is supported by gastroenterology and colorectal surgery. The clinic performs over 9,000 standard and specialized procedures each year.

Qu biologics

Scientific Advisory Board

Qu Biologics · 2005 - Present

Qu Biologics was founded in 2007 by physician Dr. Hal Gunn and businessman and cancer survivor Rob Freeman. The company’s vision began with a desire to develop treatments that re-establish health by restoring the body’s normal immune function and innate capacity to heal. This vision continues to guide us today. Qu Biologics’ Site Specific Immunomodulators (SSIs) are designed to stimulate activated innate immune cell recruitment to the targeted organ or tissue to restore immune function and treat a range of chronic diseases, including cancer and inflammatory bowel disease.


University of british columbia department of medicine


University of British Columbia Department of Medicine · 2009

Harvard medical school massachusetts general hospital

Advanced Inflammatory Bowel Disease Fellowship

Harvard Medical School - Massachusetts General Hospital · 2006

Harvard medical school


Harvard Medical School · 2004 - 2005

University of toronto

Fellowship, Gastroenterology

University of Toronto · 2002 - 2005


Dr. Brian Bressler has been involved in 89 publications. View publications ›


Dr. Brian Bressler is affiliated with GI Research Institute at Suite 770-1190 Hornby Street, Vancouver BC .